Session Details

Nanovesicular therapeutics (NVTs) are expected to have entirely novel properties in targeted drug delivery, providing a promising therapeutic platform for diseases with previously untreatable molecular targets or high unmet clinical need.

Various concepts and technologies have been developed, such as the use of externally loaded nanovesicles or naturally secreted extracellular vesicles from unmodified or genetically modified cells from different starting materials.
 

Artificially formed nanovesicular structures generated by serial extrusion techniques from living cells or hybrid constructs derived from a combination of synthetic and biological materials are increasingly being investigated. Few clinical trials have been conducted to date, and proof of efficacy in pivotal studies is still pending, yet expectations are high. This session is devoted to the technological considerations of NVT and the associated therapeutic prospects.